Find Pyrantel Pamoate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

0

South Africa

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

173RELATED EXCIPIENT COMPANIES

279EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 22204-24-6, Pyrantel embonate, Antiminth, Combantrin, Pyrantel (pamoate), Cp-10,423-16
Molecular Formula
C34H30N2O6S
Molecular Weight
594.7  g/mol
InChI Key
AQXXZDYPVDOQEE-MXDQRGINSA-N
FDA UNII
81BK194Z5M

Pyrantel Pamoate
Broad spectrum antinematodal anthelmintic used also in veterinary medicine.
1 2D Structure

Pyrantel Pamoate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4-[(3-carboxy-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic acid;1-methyl-2-[(E)-2-thiophen-2-ylethenyl]-5,6-dihydro-4H-pyrimidine
2.1.2 InChI
InChI=1S/C23H16O6.C11H14N2S/c24-20-16(14-7-3-1-5-12(14)9-18(20)22(26)27)11-17-15-8-4-2-6-13(15)10-19(21(17)25)23(28)29;1-13-8-3-7-12-11(13)6-5-10-4-2-9-14-10/h1-10,24-25H,11H2,(H,26,27)(H,28,29);2,4-6,9H,3,7-8H2,1H3/b;6-5+
2.1.3 InChI Key
AQXXZDYPVDOQEE-MXDQRGINSA-N
2.1.4 Canonical SMILES
CN1CCCN=C1C=CC2=CC=CS2.C1=CC=C2C(=C1)C=C(C(=C2CC3=C(C(=CC4=CC=CC=C43)C(=O)O)O)O)C(=O)O
2.1.5 Isomeric SMILES
CN1CCCN=C1/C=C/C2=CC=CS2.C1=CC=C2C(=C1)C=C(C(=C2CC3=C(C(=CC4=CC=CC=C43)C(=O)O)O)O)C(=O)O
2.2 Other Identifiers
2.2.1 UNII
81BK194Z5M
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Antiminth

2. Combantrin

3. Embonate, Pyrantel

4. Embovin

5. Pamoate, Pyrantel

6. Pyrantel Embonate

2.3.2 Depositor-Supplied Synonyms

1. 22204-24-6

2. Pyrantel Embonate

3. Antiminth

4. Combantrin

5. Pyrantel (pamoate)

6. Cp-10,423-16

7. Pyrantel (as Pamoate)

8. Embovin

9. (e)-1,4,5,6-tetrahydro-1-methyl-2-(2-(2-thienyl)vinyl)pyrimidine 4,4'-methylenebis(3-hydroxy-2-naphthoate) (1:1)

10. Nsc-355080

11. Chebi:8655

12. Cp 10423-16

13. 81bk194z5m

14. Nsc355080

15. (e)-1-methyl-2-(2-(thiophen-2-yl)vinyl)-1,4,5,6-tetrahydropyrimidine 4,4'-methylenebis(3-hydroxy-2-naphthoate)

16. Cp-10423-16

17. Cp-10423-18

18. Pyrimidine, 1,4,5,6-tetrahydro-1-methyl-2-(2-(2-thienyl)ethenyl)-, (e)-, Compd. With 4,4'-methylenebis(3-hydroxy-2-naphthalenecarboxylic Acid) (1:1)

19. Cobantril

20. Sentry Hc Worm X

21. 2-naphthalenecarboxylic Acid, 4,4'-methylenebis[3-hydroxy-, Compd. With 1,4,5,6-tetrahydro-1-methyl-2-[(1e)-2-(2-thienyl)ethenyl]pyrimidine (1:1)

22. 4-[(3-carboxy-2-hydroxy-1-naphthyl)methyl]-3-hydroxy-naphthalene-2-carboxylic Acid; 1-methyl-2-[(e)-2-(2-thienyl)vinyl]-5,6-dihydro-4h-pyrimidine

23. 4-[(3-carboxy-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic Acid;1-methyl-2-[(e)-2-thiophen-2-ylethenyl]-5,6-dihydro-4h-pyrimidine

24. Sentry Hc Worm X Ds

25. Einecs 244-837-1

26. Vetscription Sure Shot 2x

27. Nsc 355080

28. Pyirantelpamoate

29. Unii-81bk194z5m

30. Pyrantel Pamoates

31. Pyranteli Embonas

32. Antiminth (tn)

33. Pyrantel Pamoate [usan:usp:jan]

34. 2-naphthalenecarboxylic Acid, 4,4'-methylenebis(3-hydroxy-, Compd. With 1,4,5,6-tetrahydro-1-methyl-2-((1e)-2-(2-thienyl)ethenyl)pyrimidine (1:1)

35. Spectrum5_001373

36. Pyrantel Pamoate, Bioxtra

37. (3-hydroxy-2-naphthoate)

38. Schembl41025

39. 2-naphthalenecarboxylic Acid, 4,4'-methylenebis(3-hydroxy-, Compd. With (e)-1,4,5,6-tetrahydro-1-methyl-2-(2-(2-thienyl)ethenyl)pyrimidine (1:1)

40. Pyrantel Pamoate [mi]

41. Spectrum1500517

42. Pyrantel Pamoate [jan]

43. Pyrantel Pamoate (jp17/usp)

44. Schembl7793068

45. Pyrantel Pamoate [usan]

46. Chembl1599768

47. Pyrantel Pamoate [vandf]

48. Hms500m16

49. Pyrantel Pamoate Sigmaultra,(s)

50. Amy3564

51. Dtxsid40897057

52. Pyrantel Embonate [mart.]

53. Pyrantel Pamoate [usp-rs]

54. Hms1920n06

55. Hms2090j21

56. Hms2092e07

57. Pharmakon1600-01500517

58. Pyrantel Embonate [who-dd]

59. Pyrantel Embonate [who-ip]

60. Ccg-39242

61. Mfcd00072037

62. Nsc757303

63. S2501

64. Stl481883

65. Pyrantel Pamoate [green Book]

66. Akos015908224

67. Cs-3869

68. Nsc-757303

69. Idi1_000254

70. Pyrantel Embonate [ep Monograph]

71. Pyrantel Pamoate [usp Monograph]

72. Ncgc00094552-01

73. Ncgc00094552-02

74. Ncgc00094552-03

75. Pyranteli Embonas [who-ip Latin]

76. 2-naphthoic Acid, 4,4'-methylenebis(3-hydroxy-, Compd. With (e)-1,4,5,6-tetrahydro-1-methyl-2-(2-(2-thienyl)vinyl)pyrimidine (1:1)

77. 4,4'-methylenebis(3-hydroxy-2-naphthoic) Acid, Compound With (e)-1,4,5,6-tetrahydro-1-methyl-2-(2-(2-thienyl)vinyl)pyrimidine (1:1)

78. Ac-24204

79. As-12185

80. Bp166202

81. Hy-12640

82. Sbi-0051499.p003

83. C07389

84. D00486

85. F21340

86. 204p246

87. A816013

88. Sr-05000001708

89. Q3489331

90. Sr-05000001708-1

91. Pyrantel Pamoate, Vetranal(tm), Analytical Standard

92. (e)-1-methyl-2-(2-(thiophen-2-yl)vinyl)-1,4,5,6

93. Pyrantel Embonate, European Pharmacopoeia (ep) Reference Standard

94. Pyrantel Pamoate, United States Pharmacopeia (usp) Reference Standard

95. Pyrimidine,1,4,5,6-tetrahydro-1-methyl-2-[(1e)-2-(2-thienyl)ethenyl]-

96. (e)-1,5,6-tetrahydro-1-methyl-2-[2-(2-thienyl)vinyl]pyrimidine 4,4'-methylenebis[3-hydroxy-2-naphthoate] (1:1)

97. 2-naphthalenecarboxylic Acid,4'-methylenebis[3-hydroxy-, Compd. With (e)-1,4,5,6-tetrahydro-1-methyl-2-[2-(2-thienyl)ethenyl]pyrimidine (1:1)

98. 2-naphthoic Acid,4'-methylenebis[3-hydroxy-, Compd. With (e)-1,4,5,6-tetrahydro-1-methyl-2-[2-(2-thienyl)vinyl]pyrimidine (1:1)

99. 4,4'-methanediylbis(3-hydroxynaphthalene-2-carboxylic Acid) - 1-methyl-2-[(e)-2-(thiophen-2-yl)ethenyl]-1,4,5,6-tetrahydropyrimidine (1:1)

100. 4-[(3-carboxy-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic Acid,1-methyl-2-[(e)-2-thiophen-2-ylethenyl]-5,6-dihydro-4h-pyrimidine

101. Pyrimidine, 1,4,5,6-tetrahydro-1-methyl-2-[2-(-2-thienyl)ethenyl-, (e)-, With 4,4'-methylenebis[3-hydroxy-2-naphthalenecarboxylic Acid (1:1)

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 594.7 g/mol
Molecular Formula C34H30N2O6S
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count8
Rotatable Bond Count6
Exact Mass594.18245785 g/mol
Monoisotopic Mass594.18245785 g/mol
Topological Polar Surface Area159 Ų
Heavy Atom Count43
Formal Charge0
Complexity816
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Antinematodal Agents

Substances used in the treatment or control of nematode infestations. They are used also in veterinary practice. (See all compounds classified as Antinematodal Agents.)


Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Solubilizers

read-more
read-more

Direct Compression

read-more
read-more

Parenteral

read-more
read-more

Coating Systems & Additives

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Taste Masking

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Granulation

read-more
read-more

Lubricants & Glidants

read-more
read-more

Co-Processed Excipients

read-more
read-more

Topical

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

API Stability Enhancers

read-more
read-more

Emulsifying Agents

read-more
read-more

Controlled & Modified Release

read-more
read-more

Rheology Modifiers

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Soft Gelatin

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for 22204-24-6 / Pyrantel Pamoate API manufacturers, exporters & distributors?

Pyrantel Pamoate manufacturers, exporters & distributors 1

70

PharmaCompass offers a list of Pyrantel Pamoate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Pyrantel Pamoate manufacturer or Pyrantel Pamoate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pyrantel Pamoate manufacturer or Pyrantel Pamoate supplier.

API | Excipient name

Pyrantel Pamoate

Synonyms

22204-24-6, Pyrantel embonate, Antiminth, Combantrin, Pyrantel (pamoate), Cp-10,423-16

Cas Number

22204-24-6

Unique Ingredient Identifier (UNII)

81BK194Z5M

About Pyrantel Pamoate

Broad spectrum antinematodal anthelmintic used also in veterinary medicine.

Combantrin Manufacturers

A Combantrin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Combantrin, including repackagers and relabelers. The FDA regulates Combantrin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Combantrin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Combantrin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Combantrin Suppliers

A Combantrin supplier is an individual or a company that provides Combantrin active pharmaceutical ingredient (API) or Combantrin finished formulations upon request. The Combantrin suppliers may include Combantrin API manufacturers, exporters, distributors and traders.

click here to find a list of Combantrin suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Combantrin USDMF

A Combantrin DMF (Drug Master File) is a document detailing the whole manufacturing process of Combantrin active pharmaceutical ingredient (API) in detail. Different forms of Combantrin DMFs exist exist since differing nations have different regulations, such as Combantrin USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Combantrin DMF submitted to regulatory agencies in the US is known as a USDMF. Combantrin USDMF includes data on Combantrin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Combantrin USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Combantrin suppliers with USDMF on PharmaCompass.

Combantrin JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Combantrin Drug Master File in Japan (Combantrin JDMF) empowers Combantrin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Combantrin JDMF during the approval evaluation for pharmaceutical products. At the time of Combantrin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Combantrin suppliers with JDMF on PharmaCompass.

Combantrin CEP

A Combantrin CEP of the European Pharmacopoeia monograph is often referred to as a Combantrin Certificate of Suitability (COS). The purpose of a Combantrin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Combantrin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Combantrin to their clients by showing that a Combantrin CEP has been issued for it. The manufacturer submits a Combantrin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Combantrin CEP holder for the record. Additionally, the data presented in the Combantrin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Combantrin DMF.

A Combantrin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Combantrin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Combantrin suppliers with CEP (COS) on PharmaCompass.

Combantrin WC

A Combantrin written confirmation (Combantrin WC) is an official document issued by a regulatory agency to a Combantrin manufacturer, verifying that the manufacturing facility of a Combantrin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Combantrin APIs or Combantrin finished pharmaceutical products to another nation, regulatory agencies frequently require a Combantrin WC (written confirmation) as part of the regulatory process.

click here to find a list of Combantrin suppliers with Written Confirmation (WC) on PharmaCompass.

Combantrin NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Combantrin as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Combantrin API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Combantrin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Combantrin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Combantrin NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Combantrin suppliers with NDC on PharmaCompass.

Combantrin GMP

Combantrin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Combantrin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Combantrin GMP manufacturer or Combantrin GMP API supplier for your needs.

Combantrin CoA

A Combantrin CoA (Certificate of Analysis) is a formal document that attests to Combantrin's compliance with Combantrin specifications and serves as a tool for batch-level quality control.

Combantrin CoA mostly includes findings from lab analyses of a specific batch. For each Combantrin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Combantrin may be tested according to a variety of international standards, such as European Pharmacopoeia (Combantrin EP), Combantrin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Combantrin USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty